Ieq Capital LLC Buys New Shares in CVS Health Corporation $CVS

Ieq Capital LLC bought a new position in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 193,784 shares of the pharmacy operator’s stock, valued at approximately $20,047,000.

Several other large investors have also recently bought and sold shares of CVS. Kilter Group LLC bought a new stake in shares of CVS Health during the 2nd quarter worth approximately $27,000. Beaird Harris Wealth Management LLC grew its stake in shares of CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 195 shares in the last quarter. J.Safra Asset Management Corp acquired a new position in CVS Health during the second quarter worth $30,000. Dunhill Financial LLC acquired a new position in CVS Health during the second quarter worth $32,000. Finally, Swiss RE Ltd. bought a new stake in CVS Health during the fourth quarter worth $26,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Robert W. Baird set a $107.00 target price on shares of CVS Health in a research note on Thursday, August 6th. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Morgan Stanley boosted their price target on CVS Health from $106.00 to $111.00 and gave the stock an “overweight” rating in a research report on Thursday, June 4th. Finally, Wells Fargo & Company raised their price objective on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Twenty-two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Price Performance

NYSE:CVS opened at $93.01 on Friday. The company has a market cap of $118.96 billion, a P/E ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The firm’s fifty day moving average price is $102.02 and its two-hundred day moving average price is $88.86. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter last year, the company posted $1.81 EPS. CVS Health’s quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date was Thursday, July 23rd. CVS Health’s payout ratio is currently 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.